A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06080490` - Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients
Completed	`NCT00001637` - Immunosuppressive Preparation Followed by Blood Cell Transplant for the Treatment of Blood Cancers in Older Adults	Phase 2
Withdrawn	`NCT04728646` - Evaluation of Dextenza in Patients With Ocular GVHD and Effects on Ocular Surface Disease Outcomes	Phase 4
Suspended	`NCT01972438` - A Randomized, Controlled, Double-masked, Clinical Trial of Autologous Serum Eye Drops for Severe Ocular Chronic Graft-versus-host Disease (GVHD) in Hematopoietic Stem Cell Transplant (HSCT) Patients	Phase 1/Phase 2
Completed	`NCT01221766` - Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease	N/A
Recruiting	`NCT01764100` - Mesenchymal Stromal Cells (MSCs) for the Treatment of Graft Versus Host Disease (GVHD)	Phase 1
Terminated	`NCT00298324` - Myfortic - Treatment for Extensive cGvHD	Phase 3
Completed	`NCT00224874` - Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)	Phase 2
Completed	`NCT00023530` - Blood and Marrow Transplant Clinical Research Network	N/A
Completed	`NCT00023491` - Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells	N/A
Recruiting	`NCT05111834` - IRENE-G Study: Impact of Resistance Exercise and Nutritional Endorsement on GvHD Symptoms	N/A
Completed	`NCT02841995` - A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host Disease	Phase 2
Recruiting	`NCT06143501` - Alterations in Intestinal Microbiota, Metabolites, and Immune Cells in Allo-HSCT
Recruiting	`NCT04622956` - GVHD Prophylaxis With Methotrexate in Haploidentical HCT Using Posttransplant Cyclophosphamide	Phase 1/Phase 2
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Recruiting	`NCT03836690` - Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation	Phase 1
Not yet recruiting	`NCT02506231` - The Effect of Folinic Acid Rescue Following MTX GVHD Prophylaxis on Regimen Related Toxicity and Transplantation Outcome	Phase 2/Phase 3
Recruiting	`NCT01042509` - Combination of Alemtuzumab and Rituximab at Low-doses in Refractory Chronic Graft-Versus-Host Disease	N/A
Terminated	`NCT00117702` - Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus	Phase 2/Phase 3
Recruiting	`NCT04044365` - Pediatric cGVHD Symptom Scale

NCT number	NCT00760981
Study type	Interventional
Source	Stanford University
Contact
Status	Completed
Phase	Phase 1
Start date	September 2008
Completion date	April 2012

A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms